What an F.D.A. Committee Weighed in Voting for the Pfizer COVID Vaccine

There are things we still do not know about the COVID-19 vaccine, however everything we do understand looks great. Picture by Ben Birchall/ Swimming Pool/ EPA-EFE/ Shutterstock

An all-day hearing of the Food and Drug Administration’s vaccine advisory committee closed, on Thursday evening, with a vote to recommend an Emergency Situation Usage Authorization of the Pfizer-BioNTech COVID-19 vaccine for people sixteen and older. An F.D.A. analysis of the raw data, released previously this week, confirmed previous reports that the vaccine’s effectiveness in avoiding disease in trial participants was close to ninety-five per cent.

http://medicalbillingcodingonline.org/what-an-f-d-a-committee-weighed-in-voting-for-the-pfizer-covid-vaccine/